PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
14.66%
Some net income increase while AVGO is negative at -30.23%. John Neff would see a short-term edge over the struggling competitor.
-2.06%
Negative yoy D&A while AVGO is 11.30%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
12.28%
Some yoy growth while AVGO is negative at -101.79%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-21.43%
Negative yoy SBC while AVGO is 10.53%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
231.82%
Slight usage while AVGO is negative at -250.00%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-17.50%
AR is negative yoy while AVGO is 95.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
378.05%
Inventory growth well above AVGO's 100.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
-41.18%
Both negative yoy AP, with AVGO at -152.73%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
358.10%
Growth well above AVGO's 110.53%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-23.08%
Negative yoy while AVGO is 243.33%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
71.83%
Some CFO growth while AVGO is negative at -10.71%. John Neff would note a short-term liquidity lead over the competitor.
-11.20%
Negative yoy CapEx while AVGO is 16.38%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
11.20%
Acquisition growth of 11.20% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
50.05%
Purchases growth of 50.05% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
13.95%
Liquidation growth of 13.95% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
-14.78%
Both yoy lines negative, with AVGO at -100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
323.56%
We have mild expansions while AVGO is negative at -263.76%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-200.00%
Both yoy lines negative, with AVGO at -96.36%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
-31.37%
Both yoy lines negative, with AVGO at -29.11%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
-20.80%
We cut yoy buybacks while AVGO is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.